slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 11,191-11,220
Pages 819
Rows per page 30
Slide function
11,191-11,220 of 24,547
10
The slide uses a numbered list (1-3) to map specific platform features to corresponding visual elements in the software screenshot.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
11
The slide uses a process-like flow from left (ML identification) to right (care outcomes).Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
12
The slide uses a two-column layout: left side details the value proposition/workflow, right side shows quantitative adoption metrics.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
20
The chart uses a 2x2 matrix style to show competitive positioning.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
25
The slide uses a hub-and-spoke diagram to illustrate how the Clover Assistant platform connects to different patient segments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
44
Uses a before-after comparison framework to highlight value proposition.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
07
The slide highlights technical capabilities and productivity metrics at the bottom.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a biological interaction map to demonstrate the breadth of the company's target library.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific constructs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The diagram shows a multi-step process involving opsonization, NK cells, macrophages, dendritic cells (DC), and T-cell activation via CD137.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
27
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
28
The slide uses a process flow to show the transition from screening to hypothesis testing and final validation.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
29
The slide presents two distinct experimental results: a western blot for PD-1 and a line graph for CD28-His-APC binding.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
30
The slide uses a biological diagram to contrast the efficacy of standard PD-1 inhibitors versus the proprietary CTX-8371 molecule.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
35
The slide shows dose-response curves for specific lysis of tumor cells, highlighting the potency of NKp30-based bispecifics.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
38
The slide outlines a dual-track strategy: oncology (solid tumors) and autoimmune diseases.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
04
The slide outlines a $31m purchase price with a $74m earnout potential based on EBIT targets.Embracer Group | Mergers and Acquisitions Presentation Deck | 31 slides · Embracer Group
Conference presentation Investment bank Beat · Problem1 hit
19
The chart uses a waterfall-style visualization to show the progression of project value through milestones.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
24
The slide uses a circular diagram to represent the platform's scope and a lighthouse metaphor to emphasize its role as a guiding technology.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
27
Uses a before-after framing to contrast the burden of disease management with the potential of a curative therapy.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
33
The slide highlights the strategic alliance between Bayer and Evotec, combining expertise in inflammation/women's health with pain research.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
50
Evotec | Investor Day Presentation Deck | 103 slidesEvotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
52
Includes a process flow diagram at the bottom.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
61
The slide uses a process flow to explain the drug discovery methodology.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
62
The central chart is a UMAP projection showing the transition from a diseased state to a healthy state, with a branch for unwanted/toxic effects.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
71
The slide uses a chronological progression to frame the company's strategic development.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
74
Uses a funnel diagram to represent the R&D process from target to IND.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit